Treatment of Lymphangioleiomyomatosis
To the Editor: The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 1991-07, Vol.325 (1), p.63-64 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 64 |
---|---|
container_issue | 1 |
container_start_page | 63 |
container_title | The New England journal of medicine |
container_volume | 325 |
creator | Goodenberger, Daniel M Dhand, Sandeep Eliasson, Arn H Phillips, Yancy Y Tenholder, Michael F Goodwin, Thomas Murphy Zahner, Johannes Borst, Mathias M Worth, Heinrich Raffin, Thomas A Taylor, James R Ryu, Jay Colby, Thomas V |
description | To the Editor:
The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable clinical benefit, they continue to recommend it as second-line therapy because studies to date cannot exclude a possible benefit. Perhaps the following hypothetical encounter with a patient will illustrate my point.
"Mr. Jones, your open-lung biopsy showed a form of interstitial lung disease about which we know very little. The natural history . . . |
doi_str_mv | 10.1056/NEJM199107043250115 |
format | Article |
fullrecord | <record><control><sourceid>mms_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1056_NEJM199107043250115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NJ199107043250115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c287t-976211ea01025aaf83481e5ce9c4d495ec717fe5fdb8e772bfad0458308f5d93</originalsourceid><addsrcrecordid>eNp9j0tLw0AUhQdRaqz-AhG6cSXRe-eRmVlKqS-ibrIPk-SOpnSakomL_nsjKa7EszmLw3fgY-wS4RZBZXdvq5dXtBZBgxRcAaI6YgkqIVIpITtmCQA3qdRWnLKzGNcwBqWdsRkHmWlUCbsuenJDoO2w6Pwi34fdp9t-tN2G2i7su-CGLrbxnJ14t4l0ceg5Kx5WxfIpzd8fn5f3eVpzo4fU6owjkgMErpzzRkiDpGqytWykVVRr1J6UbypDWvPKuwakMgKMV40Vcyam27rvYuzJl7u-Da7flwjlj3L5h_JIXU3U7qsK1PwyB8dxv5n2EGK5pXX49-0bRDBc-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment of Lymphangioleiomyomatosis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Goodenberger, Daniel M ; Dhand, Sandeep ; Eliasson, Arn H ; Phillips, Yancy Y ; Tenholder, Michael F ; Goodwin, Thomas Murphy ; Zahner, Johannes ; Borst, Mathias M ; Worth, Heinrich ; Raffin, Thomas A ; Taylor, James R ; Ryu, Jay ; Colby, Thomas V</creator><creatorcontrib>Goodenberger, Daniel M ; Dhand, Sandeep ; Eliasson, Arn H ; Phillips, Yancy Y ; Tenholder, Michael F ; Goodwin, Thomas Murphy ; Zahner, Johannes ; Borst, Mathias M ; Worth, Heinrich ; Raffin, Thomas A ; Taylor, James R ; Ryu, Jay ; Colby, Thomas V</creatorcontrib><description>To the Editor:
The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable clinical benefit, they continue to recommend it as second-line therapy because studies to date cannot exclude a possible benefit. Perhaps the following hypothetical encounter with a patient will illustrate my point.
"Mr. Jones, your open-lung biopsy showed a form of interstitial lung disease about which we know very little. The natural history . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM199107043250115</identifier><identifier>PMID: 2046715</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Adolescent ; Combined Modality Therapy ; Female ; Humans ; Lymphangiomyoma - therapy ; Male</subject><ispartof>The New England journal of medicine, 1991-07, Vol.325 (1), p.63-64</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c287t-976211ea01025aaf83481e5ce9c4d495ec717fe5fdb8e772bfad0458308f5d93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM199107043250115$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJM199107043250115$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2046715$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goodenberger, Daniel M</creatorcontrib><creatorcontrib>Dhand, Sandeep</creatorcontrib><creatorcontrib>Eliasson, Arn H</creatorcontrib><creatorcontrib>Phillips, Yancy Y</creatorcontrib><creatorcontrib>Tenholder, Michael F</creatorcontrib><creatorcontrib>Goodwin, Thomas Murphy</creatorcontrib><creatorcontrib>Zahner, Johannes</creatorcontrib><creatorcontrib>Borst, Mathias M</creatorcontrib><creatorcontrib>Worth, Heinrich</creatorcontrib><creatorcontrib>Raffin, Thomas A</creatorcontrib><creatorcontrib>Taylor, James R</creatorcontrib><creatorcontrib>Ryu, Jay</creatorcontrib><creatorcontrib>Colby, Thomas V</creatorcontrib><title>Treatment of Lymphangioleiomyomatosis</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor:
The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable clinical benefit, they continue to recommend it as second-line therapy because studies to date cannot exclude a possible benefit. Perhaps the following hypothetical encounter with a patient will illustrate my point.
"Mr. Jones, your open-lung biopsy showed a form of interstitial lung disease about which we know very little. The natural history . . .</description><subject>Adolescent</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphangiomyoma - therapy</subject><subject>Male</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9j0tLw0AUhQdRaqz-AhG6cSXRe-eRmVlKqS-ibrIPk-SOpnSakomL_nsjKa7EszmLw3fgY-wS4RZBZXdvq5dXtBZBgxRcAaI6YgkqIVIpITtmCQA3qdRWnLKzGNcwBqWdsRkHmWlUCbsuenJDoO2w6Pwi34fdp9t-tN2G2i7su-CGLrbxnJ14t4l0ceg5Kx5WxfIpzd8fn5f3eVpzo4fU6owjkgMErpzzRkiDpGqytWykVVRr1J6UbypDWvPKuwakMgKMV40Vcyam27rvYuzJl7u-Da7flwjlj3L5h_JIXU3U7qsK1PwyB8dxv5n2EGK5pXX49-0bRDBc-w</recordid><startdate>19910704</startdate><enddate>19910704</enddate><creator>Goodenberger, Daniel M</creator><creator>Dhand, Sandeep</creator><creator>Eliasson, Arn H</creator><creator>Phillips, Yancy Y</creator><creator>Tenholder, Michael F</creator><creator>Goodwin, Thomas Murphy</creator><creator>Zahner, Johannes</creator><creator>Borst, Mathias M</creator><creator>Worth, Heinrich</creator><creator>Raffin, Thomas A</creator><creator>Taylor, James R</creator><creator>Ryu, Jay</creator><creator>Colby, Thomas V</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19910704</creationdate><title>Treatment of Lymphangioleiomyomatosis</title><author>Goodenberger, Daniel M ; Dhand, Sandeep ; Eliasson, Arn H ; Phillips, Yancy Y ; Tenholder, Michael F ; Goodwin, Thomas Murphy ; Zahner, Johannes ; Borst, Mathias M ; Worth, Heinrich ; Raffin, Thomas A ; Taylor, James R ; Ryu, Jay ; Colby, Thomas V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c287t-976211ea01025aaf83481e5ce9c4d495ec717fe5fdb8e772bfad0458308f5d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adolescent</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphangiomyoma - therapy</topic><topic>Male</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goodenberger, Daniel M</creatorcontrib><creatorcontrib>Dhand, Sandeep</creatorcontrib><creatorcontrib>Eliasson, Arn H</creatorcontrib><creatorcontrib>Phillips, Yancy Y</creatorcontrib><creatorcontrib>Tenholder, Michael F</creatorcontrib><creatorcontrib>Goodwin, Thomas Murphy</creatorcontrib><creatorcontrib>Zahner, Johannes</creatorcontrib><creatorcontrib>Borst, Mathias M</creatorcontrib><creatorcontrib>Worth, Heinrich</creatorcontrib><creatorcontrib>Raffin, Thomas A</creatorcontrib><creatorcontrib>Taylor, James R</creatorcontrib><creatorcontrib>Ryu, Jay</creatorcontrib><creatorcontrib>Colby, Thomas V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goodenberger, Daniel M</au><au>Dhand, Sandeep</au><au>Eliasson, Arn H</au><au>Phillips, Yancy Y</au><au>Tenholder, Michael F</au><au>Goodwin, Thomas Murphy</au><au>Zahner, Johannes</au><au>Borst, Mathias M</au><au>Worth, Heinrich</au><au>Raffin, Thomas A</au><au>Taylor, James R</au><au>Ryu, Jay</au><au>Colby, Thomas V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Lymphangioleiomyomatosis</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1991-07-04</date><risdate>1991</risdate><volume>325</volume><issue>1</issue><spage>63</spage><epage>64</epage><pages>63-64</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor:
The article on lymphangioleiomyomatosis (LAM) by Taylor et al. (Nov. 1 issue)* was a very useful addition to the limited literature on the disease. I take issue with one of their recommendations, however. Despite their own finding that oophorectomy is not associated with an observable clinical benefit, they continue to recommend it as second-line therapy because studies to date cannot exclude a possible benefit. Perhaps the following hypothetical encounter with a patient will illustrate my point.
"Mr. Jones, your open-lung biopsy showed a form of interstitial lung disease about which we know very little. The natural history . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>2046715</pmid><doi>10.1056/NEJM199107043250115</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 1991-07, Vol.325 (1), p.63-64 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_crossref_primary_10_1056_NEJM199107043250115 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine |
subjects | Adolescent Combined Modality Therapy Female Humans Lymphangiomyoma - therapy Male |
title | Treatment of Lymphangioleiomyomatosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T00%3A43%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-mms_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Lymphangioleiomyomatosis&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Goodenberger,%20Daniel%20M&rft.date=1991-07-04&rft.volume=325&rft.issue=1&rft.spage=63&rft.epage=64&rft.pages=63-64&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM199107043250115&rft_dat=%3Cmms_cross%3ENJ199107043250115%3C/mms_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2046715&rfr_iscdi=true |